Polyrizon Ltd.’s (NASDAQ:PLRZ) Quiet Period Set To End on December 9th

Polyrizon’s (NASDAQ:PLRZGet Free Report) quiet period will expire on Monday, December 9th. Polyrizon had issued 958,903 shares in its public offering on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. During the company’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Polyrizon Trading Down 4.1 %

Shares of Polyrizon stock opened at $1.17 on Wednesday. Polyrizon has a 52 week low of $0.77 and a 52 week high of $1.97.

About Polyrizon

(Get Free Report)

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Recommended Stories

Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.